Capital World Investors Regeneron Pharmaceuticals, Inc. Transaction History

Capital World Investors

$586 Billion
Q1 2024

A detailed history of Capital World Investors transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Capital World Investors holds 4,654,855 shares of REGN stock, worth $4.56 Billion. This represents 0.76% of its overall portfolio holdings.

Number of Shares

4,654,855

Previous 5,130,485 9.27%

Holding current value

$4.56 Billion

Previous $4.51 Billion 0.57%

% of portfolio

0.76%

Previous 0.82%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$902.69 - $993.35 $429 Million - $472 Million	-475,630 Reduced 9.27%	4,654,855 $4.48 Billion
Q4 2023 Feb 13, 2024	BUY	$775.18 - $881.7 $17.9 Million - $20.4 Million	23,146 Added 0.45%	5,130,485 $4.51 Billion
Q3 2023 Nov 13, 2023	SELL	$692.45 - $844.37 $307 Million - $374 Million	-443,043 Reduced 7.98%	5,107,339 $4.2 Billion
Q2 2023 Aug 11, 2023	SELL	$700.03 - $830.35 $196 Million - $233 Million	-280,204 Reduced 4.81%	5,550,382 $3.99 Billion
Q1 2023 May 15, 2023	SELL	$680.49 - $826.97 $280 Million - $341 Million	-411,849 Reduced 6.6%	5,830,586 $4.79 Billion

Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $11.9 Million - $12.9 Million	16,836 Added 0.27%	6,242,435 $4.5 Billion
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $5.17 Million - $6.53 Million	-9,012 Reduced 0.14%	6,225,599 $4.29 Billion
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $156 Million - $210 Million	284,777 Added 4.79%	6,234,611 $3.69 Billion
Q1 2022 May 16, 2022	BUY	$595.12 - $698.43 $373 Million - $437 Million	626,199 Added 11.76%	5,949,834 $4.16 Billion
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $1.98 Million - $2.44 Million	3,635 Added 0.07%	5,323,635 $3.36 Billion
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $6.91 Million - $8.2 Million	12,043 Added 0.23%	5,320,000 $3.22 Billion
Q2 2021 Aug 16, 2021	SELL	$472.8 - $558.54 $414 Million - $489 Million	-876,163 Reduced 14.17%	5,307,957 $2.96 Billion
Q1 2021 May 14, 2021	SELL	$446.73 - $548.2 $340 Million - $418 Million	-761,648 Reduced 10.97%	6,184,120 $2.93 Billion
Q4 2020 Feb 12, 2021	BUY	$478.3 - $607.98 $144 Million - $183 Million	301,398 Added 4.54%	6,945,768 $3.36 Billion
Q3 2020 Nov 13, 2020	SELL	$544.75 - $658.21 $159 Million - $192 Million	-290,985 Reduced 4.2%	6,644,370 $3.72 Billion
Q2 2020 Aug 14, 2020	SELL	$493.32 - $643.92 $97.6 Million - $127 Million	-197,925 Reduced 2.77%	6,935,355 $4.33 Billion
Q1 2020 May 15, 2020	SELL	$336.18 - $494.43 $403 Million - $593 Million	-1,199,144 Reduced 14.39%	7,133,280 $3.48 Billion
Q4 2019 Feb 18, 2020	BUY	$274.13 - $376.51 $34.5 Million - $47.4 Million	125,777 Added 1.53%	8,332,424 $3.13 Billion
Q3 2019 Nov 14, 2019	BUY	$273.46 - $318.39 $29.2 Million - $34 Million	106,813 Added 1.32%	8,206,647 $2.28 Billion
Q2 2019 Aug 14, 2019	BUY	$299.6 - $414.82 $182 Million - $252 Million	608,166 Added 8.12%	8,099,834 $2.54 Billion
Q1 2019 May 15, 2019	BUY	$372.08 - $439.57 $172 Million - $203 Million	462,477 Added 6.58%	7,491,668 $3.08 Billion
Q4 2018 Feb 14, 2019	BUY	$335.82 - $403.04 $217 Million - $260 Million	644,868 Added 10.1%	7,029,191 $2.63 Billion
Q3 2018 Nov 14, 2018	BUY	$351.14 - $408.51 $113 Million - $132 Million	322,051 Added 5.31%	6,384,323 $2.58 Billion
Q2 2018 Aug 14, 2018	BUY	$284.6 - $344.99 $388 Million - $470 Million	1,363,384 Added 29.02%	6,062,272 $2.09 Billion
Q1 2018 May 15, 2018	SELL	$315.82 - $393.78 $34.4 Million - $42.9 Million	-109,059 Reduced 2.27%	4,698,888 $1.62 Billion
Q4 2017 Feb 14, 2018	SELL	$358.63 - $469.95 $631 Million - $827 Million	-1,759,869 Reduced 26.8%	4,807,947 $1.81 Billion
Q3 2017 Nov 14, 2017	BUY	$431.38 - $504.0 $2.83 Billion - $3.31 Billion	6,567,816	6,567,816 $2.94 Billion

Others Institutions Holding REGN

# of Institutions

1,426

Shares Held

82.1M

Call Options Held

835K

Put Options Held

1.46M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $105B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital World Investors with notifications on news.

Account

Capital World Investors Regeneron Pharmaceuticals, Inc. Transaction History